Skip to main content
SpringerLink
Log in

Secondary Forms of Hypertension in Children

  • Chapter
Pediatric Hypertension

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

Abstract

Secondary hypertension (HTN) is HTN for which an underlying cause can be identified. In childhood, this constitutes a significant proportion of HTN requiring treatment. This is in marked contrast to the situation applicable to adults, where primary or essential HTN predominates. Current evidence suggests that 80–90% of children with severe HTN have an identifiable cause and some form of predominating renal disease. In adults the reverse applies. Normally, over 90% of adults with significantly increased blood pressure (BP) have essential HTN, with much smaller groups affected by secondary causes. However, the changing pattern in childhood, primarily owing to increasing childhood obesity, is modifying these findings, the cause of which is primary HTN in an increasing proportion of children requiring antihypertensive medication.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Leumann EP. Blood pressure and hypertension in childhood and adolescence. Ergsb Inn Med Kinderheilk 1979; 43: 109–183.

    CAS  Google Scholar 

  2. Londe S. Causes of hypertension in the young. Pediatr Clin North Am 1978; 25: 55–58.

    PubMed  CAS  Google Scholar 

  3. Cobanoglu A, Teply TF, Grunkemeir GL. Coarctation of the aorta in patients younger than 3 months. J Thorac Cardiovasc Surg 1985; 89: 128–135.

    PubMed  CAS  Google Scholar 

  4. Bagby SP. Dissection of pathogenetic factors in coarctation hypertension. In: Loggie JMH, Horan MJ, Gruskin AB, eds. NHLBI Workshop on Juvenile Hypertension. New York: Biomedical Information Corporation, 1984; 253–266.

    Google Scholar 

  5. Yagi S, Kramsch DM, Madoff IM, Hollander W. Plasma renin activity in hypertension associated with coarctation of the aorta. Am J Physiol 1968; 215: 605–610.

    PubMed  CAS  Google Scholar 

  6. Matsuyama K, Sonoda E, Nakao K, Horio Y, Yasue H. Baroceptor reflex in a patient with coarctation. Clin Cardiol 1987; 10: 535–536.

    PubMed  CAS  Google Scholar 

  7. Flynn MT, Ekstrom L, De Arce M, Costigan C, Hoey HM. Prevalence of renal malformations in Turner syndrome. Pediatr Nephrol 1996; 10: 498–500.

    PubMed  CAS  Google Scholar 

  8. Sumboonanonda A, Robinson BL, Gedroyc WMW, Saxton HM, Reidy JF, Haycock GB. Middle aortic syndrome: clinical and radiological findings. Arch Dis Child 1992; 67: 501–505.

    Google Scholar 

  9. Deal JE, Snell ME, Barratt TM, Dillon MJ. Renovascular disease in childhood. J Pediatr 1992; 121: 378–384.

    PubMed  CAS  Google Scholar 

  10. O’Neill JA, Berkowitz H, Fellows KJ, Harmon CM. Mid aortic syndromes and hypertension in childhood. J Pediatr Surg 1995; 30: 164–171.

    PubMed  Google Scholar 

  11. Wiggelinkhuizen J, Cremin BJ. Takayasu arteritis and renovascular hypertension in childhood. Pediatrics 1978; 62: 209–217.

    PubMed  CAS  Google Scholar 

  12. Wiltse HE, Goldbloom RB, Antia AU, Otteson DE, Rowe RD, Cooke RE. Infantile hypercalcaemia syndrome in twins. N Engl J Med 1996; 275: 1157–1160.

    Google Scholar 

  13. Shaddy RE, Snider AR, Silverman NH, Lutin W. Pulsed Doppler findings in patients with coarctation of the aorta. Circulation 1986; 73: 82–88.

    PubMed  CAS  Google Scholar 

  14. Boxer RA, La Corte MA, Singh S, et al. Nuclear magnetic resonance imaging in evaluation and follow up of children treated for coarctation of the aorta. J Am Coll Cardiol 1986; 7: 1095–1098.

    PubMed  CAS  Google Scholar 

  15. Rocchini AP, Rosenthal A, Barger AC, Castaneda AR, Nadas AS. Pathogenesis of paradoxical hypertension after coarctation resection. Circulation 1976; 54: 382–387.

    PubMed  CAS  Google Scholar 

  16. Leenen FHH, Balfe JA, Pelech AN, Barker GA, Balfe JW, Olley PM. Post operative hypertension after repair of coarctation of the aorta in children: protective effect of propranolol. Am Heart J 1987; 5: 1164–1173.

    Google Scholar 

  17. Wu JL, Leung MP, Karlberg J, Chiu C, Lee M, Mok CK. Surgical repair of coarctation of the aorta in neonates: factors affecting early mortality and recoarctation. Cardiovasc Surg 1995; 3: 573–578.

    PubMed  CAS  Google Scholar 

  18. Kari JA, Donald AE, Vallance DT, et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997; 52: 468–472.

    PubMed  CAS  Google Scholar 

  19. Broyer M, Guest G, Gagnadoux MF, Beurton D. Hypertension following renal transplantation in children. Pediatr Nephrol 1987; 1: 16–21.

    PubMed  CAS  Google Scholar 

  20. Baluarte HJ, Gru skin AB, Ingelfinger JR, Stablein D, Tejani A. Analysis of hypertension in children post renal transplantation—a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 1994; 8: 570–573.

    PubMed  CAS  Google Scholar 

  21. Still J L, Cottom D. Severe hypertension in childhood. Arch Dis Child 1967; 42: 34–39.

    PubMed  CAS  Google Scholar 

  22. Gill DG, Mendes da Costa B, Cameron JS, Joseph MC, Ogg CS, Chantler C. Analysis of 100 children with severe and persistent hypertension. Arch Dis Child 1976; 51: 951–956.

    PubMed  CAS  Google Scholar 

  23. Rahill WJ, Rubin MI. Hypertension in infantile polycystic renal disease. The importance of early recognition and treatment of severe HTN in polycystic renal disease. Clin Pediatr 1971; 11: 232–235.

    Google Scholar 

  24. Nash DA. Hypertension in polycystic kidney disease without renal failure. Arch Intern Med 1977; 137: 1571–1575.

    PubMed  Google Scholar 

  25. Kaplan BS, Fay J, Shah V, Dillon MJ, Barratt TM. Autosomal recessive polycystic kidney disease. Pediatr Nephrol 1989; 3: 43–49.

    PubMed  CAS  Google Scholar 

  26. Grunfeld B, Gimenez M, Liapchuc S, Mendilaharzu J, Gianantonio C. Systemic hypertension and plasma renin activity in children with the hemolytic-uremic syndrome. Int J Pediatr Nephrol 1982; 3: 211–214.

    PubMed  CAS  Google Scholar 

  27. Wallace DMH, Rothwell DL, Williams DI. Long term follow up of surgically treated vesico ureteric reflux. Br J Urol 1978; 50: 479–484.

    PubMed  CAS  Google Scholar 

  28. Goonasekera CDA, Shah V, Wade AM, Barratt TM, Dillon MJ. 15-year follow-up of renin and blood pressure in reflux nephropathy. Lancet 1996; 347: 640–643.

    PubMed  CAS  Google Scholar 

  29. Zhang Y, Bailey RR. A long term follow up of adults with reflux nephropathy. NZ Med J 1995; 108: 142–144.

    CAS  Google Scholar 

  30. Savage JM, Dillon MJ, Shah V, Barratt TM, Williams DI. Renin and blood pressure in children with renal scarring and vesico ureteric reflux. Lancet 1978;ii:441–444.

    Google Scholar 

  31. Savage JM, Koh CT, Shah V, Barratt TM, Dillon MJ. Five year prospective study of plasma renin activity and blood pressure in patients with long standing reflux nephropathy. Arch Dis Child 1987; 62: 678–682.

    PubMed  CAS  Google Scholar 

  32. Jardim H, Shah V, Savage JM, Barratt TM, Dillon MJ. Prediction of blood pressure from plasma renin activity in reflux nephropathy. Arch Dis Child 1991; 66: 1213–1216.

    PubMed  CAS  Google Scholar 

  33. Taverner D, Fletcher A, Russel GI, Bing RF, Jackson J, Swales JD, Thurston H. Chemical renal medullectomy: effect on blood pressure in normal rats. J Hypertens 1983; 1 (Suppl 2): 43–45.

    CAS  Google Scholar 

  34. Goonasekera CDA, Rees DD, Woolard P, Freud A, Shah V, Dillon MJ. Nitric oxide synthase inhibitors and hypertension in children and adolescents. J Hypertens 1997; 15: 901–909.

    PubMed  CAS  Google Scholar 

  35. Goonasekera CDA, Jardim H, Shah V, Dillon MJ. Abnormalities of erythrocyte sodium transport in reflux nephropathy. J Hum Hypertens 1996; 10: 473–476.

    PubMed  CAS  Google Scholar 

  36. Heale WF. Hypertension and reflux nephropathy. Aust Paediatr J 1997; 13: 56.

    Google Scholar 

  37. Merrick MV, Uttley WS, Wild SR. The detection of pyelonephritic scarring in children with radioisotope imaging. Brit J Radiol 1980; 53: 544–556.

    PubMed  CAS  Google Scholar 

  38. Dillon MJ, Smellie JM. Peripheral plasma renin activity, hypertension and renal scarring in children. In: Hodson CJ, Heptinstall RH, Winberg J, eds. Contributions to Nephrology. Reflux Nephropathy Update: 1983. Basel: Karger, 1984; 68–80.

    Google Scholar 

  39. Dillon MJ, Shah V, Barratt TM. Renal vein renin measurements in children with hypertension. Brit Med J 1978; 11: 168–170.

    Google Scholar 

  40. Goonasekera CDA, Shah V, Wade AM, Dillon MJ. The usefulness of renal vein renin studies in hypertensive children: a 25 year experience. Pediatr Nephrol 2002; 17: 943–949.

    PubMed  Google Scholar 

  41. Jacobson SH, Eklof O, Lins LE, Wikstad I, Winberg J. Long term prognosis of post infectious scarring in relation to radiological findings in childhood—a 27 year follow up. Pediatr Nephrol 1992; 6: 19–24.

    PubMed  CAS  Google Scholar 

  42. Watson AR, Balfe JW, Hardy BW. Renovascular hypertension in childhood: a changing perspective in management. J Pediatr 1985; 106: 366–378.

    PubMed  CAS  Google Scholar 

  43. Berglund G, Andersson O, Wilhelmson L. Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J 1976; 2: 554–556.

    PubMed  CAS  Google Scholar 

  44. Loirat C, Pillion G, Blum C. Hypertension in children: present data and problems. Adv. Nephrol 1982; 11: 65–98.

    Google Scholar 

  45. Fry WJ, Ernst CB, Stanley JC, Brinnk B. Renovascular hypertension in the pediatric patient. Arch Surg 1973; 107: 692–698.

    PubMed  CAS  Google Scholar 

  46. Stanley JC. Surgical intervention in pediatric renovascular hypertension. Child Nephrol Urol 1992; 12: 167–176.

    PubMed  CAS  Google Scholar 

  47. Leadbetter WF, Burkland CE. Hypertension in unilateral renal disease. J Urol 1938; 39: 611–626.

    Google Scholar 

  48. Lawson JB, Boerth R, Foster JH, Dean RH. Diagnosis and management of renovascular hypertension in children. Arch Surg 1977; 122: 1307–1316.

    Google Scholar 

  49. Stanley P, Gyepes MT, Olsen DL, Gates FG. Renovascular hypertension in children and adolescents. Radiology 1978; 129: 123–131.

    PubMed  CAS  Google Scholar 

  50. Makkar SP, Moorthy B. Fibromuscular dysplasia of renal arteries. An important cause of renovascular hypertension in children. J Pediatr 1979; 95: 940–945.

    Google Scholar 

  51. Wise KL, McCann RL, Dunnick NR, Paulson DF. Renovascular hypertension. J Urol 1988; 140: 911–924.

    PubMed  CAS  Google Scholar 

  52. Wells TG, Belsha CW. Pediatric renovascular hypertension. Curr Opinion Ped 1996; 8: 128–134.

    CAS  Google Scholar 

  53. Halpern M, Currarino G. Vascular lesions causing hypertension in neurofibromatosis. N Engl J Med 1965; 273: 248–252.

    Google Scholar 

  54. Mena E, Bookstein JJ, Holt JF, Fry WJ. Neurofibromatosis and renovascular hypertension in children. Am J Roentgenol 1973; 118: 39–45.

    CAS  Google Scholar 

  55. Green JF, Fitzwater JE, Burgess J. Arterial lesions associated with neurofibromatosis. Am J Clin Pathol 1974; 62: 481–487.

    Google Scholar 

  56. Muller-Wiefel DE. Renovascular hypertension bei neurofibromatose von Recklinghausen. Monatsschr Kinderheilk 1978; 126: 113–118.

    CAS  Google Scholar 

  57. Fossalli E, Signorini E, Intermite RC, et al. Renovascular disease and hypertension in children with neurofibromatosis. Pediatr Nephrol 2000; 14: 806–810.

    Google Scholar 

  58. Kaufmann JJ, Goodwin WE, Waisman J, Gyepes MT. Renovascular hypertension in children. Report of seven cases treated surgically including two cases of renal auto transplantation. Am J Surg 1972; 124: 149–157.

    Google Scholar 

  59. Loughridge LW. Renal abnormalities in the Marfan syndrome. Quart J Med 1959; 28: 531–544.

    PubMed  CAS  Google Scholar 

  60. Menser MA, Dorman DC, Reye RDK, Reid RR. Renal artery stenosis in the rubella syndrome. Lancet 1966;i:790–797.

    Google Scholar 

  61. Proesmans W. Syndrome de Kleppel-Trenaunay avec hypertension arterielle et insuffisance renale chronique. Ann Pediatr 1982; 29: 671–674.

    CAS  Google Scholar 

  62. Leenhardt A, Guillevin L, Bletry O, Godean P. Arterial hypertension in periarteritis nodosa. 37 case reports. Arch Mal Coeur Vas 1984; 77: 197–202.

    CAS  Google Scholar 

  63. Adelman RD. Neonatal hypertension. Pediatr Clin North Am 1978; 25: 99–110.

    PubMed  CAS  Google Scholar 

  64. O’Malley B, D’Angio GJ, Vawter GF. Late effects of roentgen therapy given in infancy. Am J Roentgenol 1963; 89: 1067–1074.

    Google Scholar 

  65. Koskimies O. Arterial hypertension developing 10 years after radiotherapy for Wilms’ tumour. Brit Med J 1988; 285: 996–998.

    Google Scholar 

  66. Alvestrand A, Bergstroem J, Wehle B. Phaeochromocytoma and renovascular hypertension. A case report and review of the literature. Acta Med Scand 1977; 202: 231–236.

    PubMed  CAS  Google Scholar 

  67. Palmer JM, Connelly JE. Intrarenal arterio venous fistula: surgical excision under selective renal hypothermia with kidney survival. J Urol 1966; 96: 599–605.

    PubMed  CAS  Google Scholar 

  68. Daman Willems CD, Salisbury DM, Lumley JSP, Dillon MJ. Brain revascularisation in hypertension. Arch Dis Child 1985; 60: 1177–1179.

    Google Scholar 

  69. Daniels SR, Loggie JMH, McEnery PT, Towbin RB. Clinical spectrum of intrinsic renovascular hypertension in children. Pediatrics 1986; 80: 698–704.

    Google Scholar 

  70. Dillon MJ. Investigation and management of hypertensive children. Pediatr Nephrol 1987; 1: 59–68.

    PubMed  CAS  Google Scholar 

  71. Rosendahl W, Grunert D, Schoning M. Duplex sonography of renal arteries as a diagnostic tool in hypertensive children. Eur J Pediatr 1994; 153: 588–593.

    PubMed  CAS  Google Scholar 

  72. Brun P, Kchouk H, Mouchet B. Value of Doppler ultrasound for the diagnosis of renal artery stenosis in children. Pediatr Nephrol 1997; 11: 27–30.

    PubMed  CAS  Google Scholar 

  73. Riehl J, Schmitt H, Bongartz D, Bergmann D, Sieberth HG. Renal artery stenosis: evaluation with color duplex ultra-sonography. Nephrol Dial Transplant 1997; 12: 1608–1614.

    PubMed  CAS  Google Scholar 

  74. Rosen PR, Treves S, Ingelfinger JR. Hypertension in children. Increased efficacy of Tc-99 m succinate in screening for renal disease. Am J Dis Child 1985; 139: 173–177.

    PubMed  CAS  Google Scholar 

  75. Taylor A, Nally J, Aurell M, et al. Consensus report on ACE inhibitor renography for detecting hypertension. J Nucl Med 1996; 37: 1876–1882.

    PubMed  CAS  Google Scholar 

  76. Chandar JJ, Sfakianakis GN, Zilleruelo GE, et al. ACE inhibition scintigraphy in the management of hypertension in children. Pediatr Nephrol 1999; 13: 493–500.

    PubMed  CAS  Google Scholar 

  77. Ng CS, de Bruyn R, Gordon I. Investigation of renovascular hypertension in children: the accuracy of radisotopes in detecting renovascular disease. Nucl Med Commun 1997; 18: 1017–1028.

    PubMed  CAS  Google Scholar 

  78. Dillon MJ. The diagnosis of renovascular disease. Pediatr Nephrol 1997; 11: 366–372.

    PubMed  CAS  Google Scholar 

  79. Shahdadpuri J, Frank R, Gauthier BG, Siegel DN, Trachtman H. Yield of renal arteriography in the evaluation of pediatric hypertension. Pediatr Nephrol 2000; 14: 816–819.

    PubMed  CAS  Google Scholar 

  80. Maier SE, Scheidegger MB, Liu K, Schneider E, Bollinger A, Boesiger P. Renal artery velocity mapping with MR imaging. J Magn Reson Imaging 1995; 5: 669–676.

    PubMed  CAS  Google Scholar 

  81. Olbricht CJ, Galanski M, Chavan A, Prokop M. Spiral CT angiography: can we forget about arteriography to diagnose renal artery stenosis? Nephrol Dial Transplant 1996; 11: 1227–1231.

    PubMed  CAS  Google Scholar 

  82. Dillon MJ, Deal JE. Renovascular hypertension in children. In: Novick A, Scoble J, Hamilton G, eds. Renal Vascular Disease. London: WB Saunders, 1996; 235–244.

    Google Scholar 

  83. Dillon MJ. Therapeutic strategies in renovascular hypertension. Baillières Clinical Paediatrics 1997;5:675– 686.

    Google Scholar 

  84. Sos TA, Seddekni S. Pediatric renovascular hypertension: the role of renal angioplasty. Dialog Ped Urol 1985; 8: 7–9.

    Google Scholar 

  85. Chevalier RL, Tegtmeyer CJ, Gomez RA. Percutaneous transluminal angioplasty for renovascular hypertension in children. Pediatr Nephrol 1987; 1: 89–98.

    PubMed  CAS  Google Scholar 

  86. Norling LL, Chevalier RL, Gomez RA, Tegtmeyer CJ. Use of interventional radiology for hypertension due to renal artery stenosis in children. Child Nephrol Urol 1992; 12: 162–166.

    PubMed  CAS  Google Scholar 

  87. Tegtmeyer CJ, Matsumoto AH, Angle JF. Percutaneous transluminal angioplasty in fibrous dysplasia in children. In: Novick A, Scoble J, Hamilton G, eds. Renal Vascular Disease. London: WB Saunders, 1996; 363–383.

    Google Scholar 

  88. Tyagi S, Kaul UA, Satsangi DK, Arora R. Percutaneous transluminal angioplasty for renovascular hypertension in children: Initial and long term results. Pediatrics 1997; 99: 44–49.

    CAS  Google Scholar 

  89. Davies R, Barkovics M, Gordon I, Shah V, Chan M, Dillon MJ. Percutaneous transluminal angioplasty for renovascular hypertension in children. Pediatr Nephrol 1999; 13: C53.

    Google Scholar 

  90. Dorros G, Prince C, Mathiak L. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty. Cath Cardiovasc Diagn 1993; 29: 191–198.

    CAS  Google Scholar 

  91. Trost D, Sos TA. Endovascular Stents. In: Novick A, Scoble J, Hamilton G, eds. Renal Vascular Disease. London: WB Saunders, 1996; 363–383.

    Google Scholar 

  92. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Quart J Med 1999; 92: 159–167.

    CAS  Google Scholar 

  93. Stoney RJ, Cooke PA, Stoney ST. Surgical treatment of renovascular hypertension in children. J Pediatr Surg 1975; 10: 631–639.

    PubMed  CAS  Google Scholar 

  94. Novick AC, Straffon RA, Stewart BH, Benjamin S. Surgical treatment of renovascular hypertension in the pediatric patient. J Urol 1978; 119: 794–805.

    PubMed  CAS  Google Scholar 

  95. Berkowitz HD, O’Neill JA. Renovascular hypertension in children. Surgical repair with special reference to the use of reinforced grafts. J Vasc Surg 1989; 9: 46–55.

    PubMed  CAS  Google Scholar 

  96. Sinaiko A, Najarian J, Michael AF, Mirkin BL. Renal auto transplantation in the treatment of bilateral renal artery stenosis. Relief of hypertension in an eight year old boy. J Pediatr 1973; 83: 409–413.

    PubMed  CAS  Google Scholar 

  97. Stanley JC, Zelenock GB, Messina LM, Wakefield TW. Pediatric renovascular hypertension: a thirty year experience of operative treatment. J Vasc Surg 1995; 21: 212–226.

    PubMed  CAS  Google Scholar 

  98. Steinbrecher HA, Malone PS. Wilms’ tumour and hypertension: incidence and outcome. Br J Urol 1995; 76: 241–243.

    PubMed  CAS  Google Scholar 

  99. Robertson PW, Klidjian A, Harding LK, Walters G, Lee MR, Robb-Smith AH. Hypertension due to a reninsecreting tumour. Am J Med 1967; 43: 963–976.

    PubMed  CAS  Google Scholar 

  100. Warshaw BL, Anand SK, Olsen DL, Gruskin CM, Heuser ET, Liebermann E. Hypertension secondary to a renin producing juxta glomerular cell tumour. J Pediatr 1979; 94: 247–250.

    PubMed  CAS  Google Scholar 

  101. Haab F, Duclos JM, Guyenne T, Plouin PF, Corvol P. Renin secreting tumours: diagnosis, conservative surgical approach and long term results. J Urol 1995; 153: 1781–1784.

    PubMed  CAS  Google Scholar 

  102. Hirose M, Arakawa K, Kikuchi M, Kawasaki T, Omoto T. Primary reninism with renal hamartomatous alteration. JAMA 1974; 230: 1288–1292.

    CAS  Google Scholar 

  103. Stackpole RH, Melicow MM, Uson AC. Pheochromocytoma in children. J Pediatr 1963; 63: 315–330.

    Google Scholar 

  104. Deal JE, Sever PS, Barratt TM, Dillon MJ. Phaechromocytoma—investigation and management of 10 cases. Arch Dis Child 1990; 65: 269–274.

    PubMed  CAS  Google Scholar 

  105. Glushien AS, Mansuy MM, Littman DS. Pheochromocytoma: its relationships to neurocutaneous syndromes. Am J Med 1953; 14: 318–327.

    PubMed  CAS  Google Scholar 

  106. Chapman RC, Kemp VA, Taliaferro I. Pheochromocytoma associated with multiple neurofibromatosis and intracranial hemangioma. Am J Med 1959; 26: 883–890.

    PubMed  CAS  Google Scholar 

  107. Sever PS, Roberts JC, Snell ME. Phaeochromocytoma. Clin Endocrinol Metab 1980; 9: 543–568.

    PubMed  CAS  Google Scholar 

  108. Sipple JH. The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 1961; 31: 163–166.

    Google Scholar 

  109. Keiser HR, Beaven MA, Doppman J, Wells S, Buja LM. Sipple’s syndrome, medullary thyroid carcinoma, pheochromocytoma and parathyroid disease. Studies in a large family. NIH conference. Ann Intern Med 1973; 78: 561–579.

    PubMed  CAS  Google Scholar 

  110. Lips KJ, Van der Sluys Veer L, Struyvanberg A, Bilateral occurrence of pheochromocytoma in patients with multiple endocrine neoplasia syndrome Type 2A (Sipple’s syndrome). Am J Med 1981; 70: 1051–1060.

    PubMed  CAS  Google Scholar 

  111. Koch CA, Vortmeyer AO, Huang SC, Alesci S, Zhuang Z, Pacak K. Genetic aspects of pheochromocytoma. Endocr Regul 2001; 35: 43–52.

    PubMed  CAS  Google Scholar 

  112. Bravo EL, Gifford RW. Pheochromocytoma: diagnosis, evaluation and management. N Engl J Med 1984; 311: 1298–1303.

    PubMed  CAS  Google Scholar 

  113. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 meta iodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 1985; 26: 576–585.

    PubMed  CAS  Google Scholar 

  114. Shulkin B, Shapiro B, Francis IR, Dorr R, Shen SW, Sisson JC. Primary extra-adrenal pheochromocytoma: positive I-123 MIBG imaging with negative I-131 MIBG imaging. Clin Nucl Med 1986; 11: 851–854.

    PubMed  CAS  Google Scholar 

  115. Van der Harst E, de Herder WW, Bruining HA, 123I metaiodobenzylguanidine and III In octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 2001; 86: 685–693.

    PubMed  Google Scholar 

  116. Schmedtje JF, Sax S, Pool JL, Goldfarb RA, Nelson EB. Localization of ectopic pheochromocytoma by magnetic resonance imaging. Am J Med 1987; 83: 770–772.

    PubMed  Google Scholar 

  117. Ellis D, Gartner JC. The intraoperative medical management of childhood pheochromocytoma. J Pediatr Surg 1980; 15: 655–659.

    PubMed  CAS  Google Scholar 

  118. Loriden L, Senior E. Cushing’s syndrome in infancy. J Pediatr 1969; 75: 349–359.

    Google Scholar 

  119. Krakoff LR, Garbowit D. Hypertension of Cushing’s syndrome. In: Biglieri EG, Melby JC eds. Endocrine hypertension. New York: Raven, 1990; 113–123.

    Google Scholar 

  120. Margioris AN, Chrousos GP. Cushing’s syndrome: diagnostic evaluation. In: Biglieri EG, Melby JC, eds. Endocrine hypertension. New York: Raven, 1990: 99–111.

    Google Scholar 

  121. Migeon CJ, Green OC, Eckert JP. Study of adrenocortical function in obesity. Metabolism 1963; 12: 718–739.

    PubMed  CAS  Google Scholar 

  122. Schteingart DE. Cushing’s syndrome. Endocrinol Clin North Am 1989; 18: 311–338.

    CAS  Google Scholar 

  123. Styne DM, Grumbach MM, Kaplan SL, Wilson CB, Conte FA. Treatment of Cushing’s disease in childhood and adolescence by transphenoidal microadenectomy. N Engl J Med 1984; 310: 889–893.

    PubMed  CAS  Google Scholar 

  124. McArthur RG, Hayles AB, Salassa RM. Childhood Cushing’s disease: results of bilateral adrenalectomy. J Pediatr 1979; 95: 214–219.

    PubMed  CAS  Google Scholar 

  125. Wiesen M, Ross F, Krieger DT. Prolonged remission in a case of Cushing’s disease following cessation of cyproheptadine therapy. Acta Endocrinol 1983; 102: 436–438.

    PubMed  CAS  Google Scholar 

  126. De Santo NG, Anastasio P, Spitali L, et al. Endocrine-metabolic hypertension. Child Nephrol Urol 1992; 12: 147–153.

    Google Scholar 

  127. New MI, Levine LS. Adreno cortical hypertension. Pediatr Clin North Am 1978; 25: 67–81.

    PubMed  CAS  Google Scholar 

  128. Dacon-Voutetakis C, Maniati-Christidi M, Dracopoulou-Vabouli M. Genetic aspects of congenital adrenal hyperplasia. J Pediatr Endocrinol Metal 2001; 14 (Suppl 5): 1303–1308.

    Google Scholar 

  129. Rauh W, Oberfeld SF. The adrenal cortex in childhood hypertension. Paediatr Adolesc Endocrinol 1984; 13: 210–230.

    Google Scholar 

  130. Jackson RV, Lafferty A, Torpy DJ, Stratakis C. New genetic insights in familial hyperaldosteronism. Ann NY Acad Sci 2002; 970: 77–88.

    PubMed  CAS  Google Scholar 

  131. Whorwood CB, Stewart PM. Human hypertension caused by mutations in the 11 beta-hydnoxy steroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess. J Hypertens Suppl 1996; 14: S19–S24.

    PubMed  CAS  Google Scholar 

  132. Hansson JH, Nelson-Williams C, Suzuki K, et al. Hypertension caused by a truncated epithelial sodium channel gamma sub unit: genetic heterogeneity in Liddle’s syndrome. Nat Genet 1995; 11: 76–82.

    PubMed  CAS  Google Scholar 

  133. Archard JM, Disse-Nicodeme S, Fiquet-Kempf B, Jeunemaitre X. Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome). Clin Exp Pharmacol Physiol 2001; 28: 1048–1052.

    Google Scholar 

Download references

Authors
  1. Michael J. Dillon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Pediatric Nephrology and Hypertension, University of Texas-Houston, Medical School, Houston, TX, USA

    Ronald J. Portman MD (Chairman, Executive Committee, International Pediatric Hypertension Association, and Professor and Director) & Jonathan M. Sorof MD (Vice Chairman, Executive Committee, International Pediatric Hypertension Association, and Associate Professor) (Chairman, Executive Committee, International Pediatric Hypertension Association, and Professor and Director) &  (Vice Chairman, Executive Committee, International Pediatric Hypertension Association, and Associate Professor)

  2. Department of Pediatrics, Harvard Medical School, and Division of Pediatric Nephrology, Massachusetts General Hospital, Boston, MA, USA

    Julie R. Ingelfinger MD (Liaison, Executive Committee, International Pediatric Hypertension Association, Professor of Pediatrics, Senior Consultant in Pediatric Nephrology) (Liaison, Executive Committee, International Pediatric Hypertension Association, Professor of Pediatrics, Senior Consultant in Pediatric Nephrology)

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dillon, M.J. (2004). Secondary Forms of Hypertension in Children. In: Portman, R.J., Sorof, J.M., Ingelfinger, J.R. (eds) Pediatric Hypertension. Clinical Hypertension and Vascular Diseases. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-797-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-797-0_9

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6149-8

  • Online ISBN: 978-1-59259-797-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation